The Senate Parliamentarian reversed course on a small provision in the One Big Beautiful Bill Act that could boost cures for rare diseases.

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the ...

The Orphan Cures Act has been added back into the Senate version of President Donald Trump’s “big, beautiful bill” after being ...

Medicare is negotiating the prices of 15 drugs, including Novo Nordisk's Ozempic. The government has until Nov. 30 to announce the agreed-upon Medicare prices.

The Medicare Drug Price Negotiation Program, Year Two: Effects On Access And Innovation Laura Tollen June 3, 2025 Doi: 10.1377/forefront.20250602.732579 ...

The Choose Medicare Act would establish a Medicare Part E that would give employers and the general public the ability to opt ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.

The Senate megabill has gone through what Republicans hope will be its final “Byrd bath” — and the chamber will be working ...

Patients covered by UnitedHealthcare Medicare Advantage plans will soon find their insurance no longer accepted at Brown ...